AB0884 Serum fibroblast growth factor-23 levels were higher in patients with axial spondyloartrhriti...
AB0884 Serum fibroblast growth factor-23 levels were higher in patients with axial spondyloartrhritis and may be associated with disease activity
About this item
Full title
Author / Creator
Gercik, O. , Coban, E. , Ozbek Iptec, B. , Avcioglu, G. , Solmaz, D. , Bayindir, O. , Kabadayi, G. , Kozaci, D. and Akar, S.
Publisher
Kidlington: Elsevier Limited
Journal title
Language
English
Formats
Publication information
Publisher
Kidlington: Elsevier Limited
Subjects
More information
Scope and Contents
Contents
BackgroundAxial spondyloarthritis (axSpA) is a chronic inflammatory disease that mainly affects axial skeleton. The disease is characterised by new bone formation; it usually starts with the bony fusion of sacroiliac joints (SIJs) and also causes syndesmophyte formation in the intervertebral space, enthesophytes in the tendon and ligament insertion...
Alternative Titles
Full title
AB0884 Serum fibroblast growth factor-23 levels were higher in patients with axial spondyloartrhritis and may be associated with disease activity
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_journals_2071149423
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2071149423
Other Identifiers
ISSN
0003-4967
E-ISSN
1468-2060
DOI
10.1136/annrheumdis-2018-eular.2828
